KYTX: Kyverna Therapeutics, Inc. Stock

by  •  • Comments Off on KYTX: Kyverna Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 648.02
Enterprise Value ($M) 793.95
Book Value ($M) 49.18
Book Value / Share 1.14
Price / Book 13.18
NCAV ($M) 34.65
NCAV / Share 0.80
Price / NCAV 18.70

Profitability (mra)
Return on Invested Capital (ROIC) -1.04
Return on Assets (ROA) -0.90
Return on Equity (ROE) -1.29

Liquidity (mrq)
Quick Ratio 3.05
Current Ratio 3.05

Balance Sheet (mrq) ($M)
Current Assets 60.66
Assets 75.19
Liabilities 26.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -62.41
Net Income -60.37

Cash Flow Statement (mra) ($M)
Cash From Operations -52.41
Cash from Investing -8.79
Cash from Financing 58.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13D Vida Ventures, LLC 11.10
02-22 13G Northpond Ventures III, LP 7.60
02-20 13G Gilead Sciences Inc 9.60
02-14 13G Bain Capital Life Sciences Opportunities III, LP 7.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 40,837 447,253 9.13
2024-05-02 78,856 133,450 59.09
2024-05-01 131,949 167,173 78.93
2024-04-30 93,065 158,577 58.69

(click for more detail)

Similar Companies
KRON – Kronos Bio, Inc. KRYS – Krystal Biotech, Inc.
KURA – Kura Oncology, Inc. KZR – Kezar Life Sciences, Inc.
LVTX – LAVA Therapeutics N.V.


Financial data and stock pages provided by
Fintel.io